Figure 1From: Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trialImmunochistochemistry for AREG, EREG, Hif-1 α, VEGF-C, VEGF-D, VEGFR-3 and PTEN in tumour tissues obtained from patients with stage II/III CRC. According to the intensity and extend the stained tumor area samples were classified as positive or negative.Back to article page